Cholecystectomy vs EUS-guided GBD With Stone Removal
Cholelithiasis
About this trial
This is an interventional treatment trial for Cholelithiasis focused on measuring Cholelithiasis, biliary, cholecystostomy, laparoscopic, cholecystectomy, gallstones
Eligibility Criteria
Inclusion Criteria: Adults >18 years old and <89 years old Adult symptomatic patients with gallstones documented by US Subject is a suitable candidate for an elective laparoscopic cholecystectomy or an EUS-guided GBD Patients or authorized representative give informed consent for endoscopic or surgical approach Exclusion Criteria: Patients with hepato-pancreato-biliary diseases other than gallstones (tumors, obstructions, inflammation) Patients with acute cholecystitis, cholangitis or choledocholithiasis. Patients with gallbladder polyps, family history of gallbladder cancer, or any other high-risk factor for gallbladder cancer Patient unable to give informed consent or refuse to participate. Prior biliary intervention Pregnancy or nursing Any other medical condition that contraindicates surgical or endoscopic procedures
Sites / Locations
- Instituto Ecuatoriano de Enfermedades Digestivas
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
EUS-GBD with stone clearance
Elective laparoscopic cholecystectomy
Patients >18-year-old with a diagnosis of gallstones by abdominal ultrasound, will be randomly allocated to EUS-guided GBD with electrocautery-enhanced lumen-apposing metal stent (LAMS) (Boston Scientific, Marlborough, MA, EEUU) with stone clearance.
Patients >18-year-old with a diagnosis of gallstones by abdominal ultrasound are randomly allocated to elective laparoscopic cholecystectomy and laparoscopic biliary exploration.